Outcomes From Remediation and Behavioural Intervention Techniques

Launched by UNIVERSITY OF TORONTO · Feb 7, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how different people with schizophrenia and related disorders respond to two types of therapy: Cognitive Behavioural Therapy for Psychosis (CBTp) and Cognitive Remediation Therapy (CR). The researchers want to understand which factors may help predict whether someone will benefit more from one type of therapy alone or if they might need both combined. This information could help tailor treatments to better meet individual needs.

To participate in this trial, you need to be between 18 and 65 years old and have a diagnosis of a schizophrenia-spectrum disorder. It’s important that you can read, write, and speak English. However, if you have a neurodevelopmental disability or have received either CBT or CR in the past six months, you won’t be eligible to join. If you decide to take part, you’ll be helping researchers learn more about effective treatments, which could improve outcomes for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18-65 years
• • Diagnosed with schizophrenia-spectrum disorders
• • Can read, write, and speak English
• Exclusion Criteria:
• • Neurodevelopmental disability or neurocognitive disorder
• • CBT or CR in the past 6 months